Mid-Atlantic Alliance for Performance Excellence (MAAPE)
1
1
0.06
1
- Areas of investment
Summary
Mid-Atlantic Alliance for Performance Excellence (MAAPE) is the famous Corporate Investor, which was founded in 2004. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Lancaster.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Mid-Atlantic Alliance for Performance Excellence (MAAPE), startups are often financed by Bristol-Myers Squibb.
The important activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually.
Among the various public portfolio startups of the fund, we may underline Jefferson Health System For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund. Among the most successful fund investment fields, there are Adult, Hospital.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Rounds per year
- 0.06
- Investments by industry
- Hospital (1)
- Medical Device (1)
- Adult (1)
- Health Care (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.